Skip to main content
SpringerLink
Log in

Risks versus Benefits of NSAIDs Including Aspirin in Myocarditis

A Review of the Evidence from Animal Studies

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

NSAIDs, including aspirin (acetylsalicylic acid), are frequently used and effective in a broad variety of inflammatory diseases, i.e. rheumatic carditis and pericarditis. Myocarditis may constitute another suitable indication for NSAIDs in order to relieve the symptoms of the presumed viral infection or because pericardial effusion is often associated with this condition. However, concerns have been raised about their indiscriminate use in myocarditis. To clarify this issue, we conducted a systematic review of the literature concerning myocarditis, aspirin and NSAIDs.

We examined five animal studies of NSAIDs (indomethacin and ibuprofen) and aspirin in coxsackievirus B3- and B4-induced myocarditis. These studies indicated a deleterious effect of NSAIDs and aspirin in this setting, demonstrating a 2- to 3-fold increase in inflammation, myocytes necrosis and even mortality when compared with placebo. This possible deleterious effect was more predominant when NSAIDs or aspirin were administered during the acute and subacute phases of myocarditis; however, it was still noted when NSAIDs were administered during the late phase of the disease (the effect of aspirin was not evaluated in late phase studies). According to these animal studies, such effect might be attributed to decreased viral clearance (possibly via interferon inhibition) and/or exaggerated cytotoxic response (via interleukin-2 or inhibition of suppressor cells factors) and/or coronary artery spasm.

We found one animal study looking at autoimmune myocarditis and it did not demonstrate any beneficial or detrimental effect of aspirin.

Moreover, recent data suggest that aspirin and NSAIDs may counteract part of the efficacy of ACE inhibitors and be deleterious in chronic heart failure.

Taken together, these studies point to a possible deleterious effect of aspirin and NSAIDs in human myocarditis. In view of these animal studies and in the absence of controlled studies of aspirin or NSAIDs in human myocarditis, we do not recommend indiscriminate treatment with NSAIDs or high-dose aspirin in patients with myocarditis where there is no or minimal associated pericarditis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

References

  1. Zee-Cheng CS, Tsai CC, Palmer DC, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates and clinical outcome. N Engl J Med 1985; 312: 885–90

    Article  Google Scholar 

  2. Aretz HT, Billingham ME, Edwards WE, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiol Pathol 1985; 1: 1–10

    Google Scholar 

  3. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past to the future. Circulation 1999; 99: 1091–100

    Article  PubMed  CAS  Google Scholar 

  4. Friman G, Wesslén L, Fohlman J, et al. The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy. Eur Heart J 1995; 16Suppl. O: 36–41

    Article  PubMed  Google Scholar 

  5. Boccara F, Benhaiem-Sigaux N, Cohen A. Acute myopericarditis after diphteria, tetanus, and polio vaccination. Chest 2001; 120: 671–2

    Article  PubMed  CAS  Google Scholar 

  6. Marcolongo R, Russo R, Laveder F, et al. Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardiol 1998; 26: 1276–9

    Article  Google Scholar 

  7. Khatib R, Reyes MP, Smith F, et al. Enhancement of coxsackievirus B4 virulence by indomethacin. J Lab Med Clin 1990; 116: 116–20

    CAS  Google Scholar 

  8. Khatib R, Reyes MP, Khatib G, et al. Focal ventricular thinning caused by indomethacin in the late phase of coxsackievirus B4 murine myocarditis. Am J Med Sci 1992; 303: 95–8

    Article  PubMed  CAS  Google Scholar 

  9. Costanzo-Nordin MR, Reap EA, O’Connell JB, et al. A nonsteroid anti-inflammatory drug exacerbates coxsackie B3 murine myocarditis. J Am Coll Cardiol 1985; 6: 1078–82

    Article  PubMed  CAS  Google Scholar 

  10. Rezkalla S, Khatib G, Khatib R. Coxsackievirus B3 myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents. J Lab Clin Med 1986; 107: 393–5

    PubMed  CAS  Google Scholar 

  11. Rezkalla S, Khatib R, Khatib G, et al. Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model. J Lab Clin Med 1988; 112: 118–21

    PubMed  CAS  Google Scholar 

  12. Zhang S, Kodama M, Hanawa H, et al. Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis. J Am Coll Cardiol 1993; 21: 1254–60

    Article  PubMed  CAS  Google Scholar 

  13. Orine IM, Shand FL. Inhibitors of prostaglandin synthetase block generation of suppressor T-cells induced by concanavalin A. Int J Immunopharmacol 1981; 3: 15–9

    Article  Google Scholar 

  14. Kodama M, Matsumoto Y, Fujiwara M, et al. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res 1991; 69: 1042–50

    Article  PubMed  CAS  Google Scholar 

  15. Parillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989; 321: 1061–8

    Article  Google Scholar 

  16. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001; 104: 39–45

    Article  PubMed  CAS  Google Scholar 

  17. Mason JW, O’Connel JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333: 269–75

    Article  PubMed  CAS  Google Scholar 

  18. Adachi Y, Yasumizu R, Hashimoto F, et al. An autopsy case of giant cell myocarditis probably due to a non-steroidal anti-inflammatory drug. Pathol Int 2001; 51: 113–7

    Article  PubMed  CAS  Google Scholar 

  19. Caforio A, McKenna WJ. Recognition and optimum management of myocarditis. Drugs 1996; 52(4): 515–25

    Article  PubMed  CAS  Google Scholar 

  20. Wayne J, Braunwald E. The cardiomyopathies and myocarditides. In: Braunwald E, editor. Heart disease: a textbook of cardiocascular medicine. 5th ed. Philadelphia (PA); W.B. Saunders 1997: 1404–61

    Google Scholar 

  21. Rheumatic Fever Working Party (RFWP) of the MRC, Great Britain, and the Subcommittee of Principal investigators of the American Council on Rheumatic Fever and Congenital heart Disease, et al. The treatment of acute rheumatic fever in children: a cooperative clinical trial of ACTH, cortisone and aspirin. Circulation 1955; 2: 343–71

    Google Scholar 

  22. Albert DA, Harel L, Karrisson T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine 1995; 74: 1–12

    Article  PubMed  CAS  Google Scholar 

  23. Arunasalam S, Siegel RJ. Rapid resolution of symptomatic acute pericarditis with ketorolac tromathamine: a parenteral nonsteroidal antiinflammatory agent. Am Heart J 1993; 125: 1455–8

    Article  PubMed  CAS  Google Scholar 

  24. Guindo J, Rodriguez de la Serna A, Ramio J, et al. Recurrent pericarditis: relief with colchicine. Circulation 1990; 82: 1117–20

    Article  PubMed  CAS  Google Scholar 

  25. Cacoub P, Sbaï A, Wechsler B, et al. Efficacy of colchicine in recurrent acute idiopathic pericarditis. Arch Mal Coeur Vaiss 2000; 93: 1511–4

    PubMed  CAS  Google Scholar 

  26. Khatib R, Khatib G, Chason JL, et al. Alteration in coxsackievirus B4 heart muscle disease in ICR Swiss mice by anti-thymocyte serum. J Gen Virol 1983; 64: 231–6

    Article  PubMed  Google Scholar 

  27. Khatib R, Chason JL, Silberberg BK, et al. Age dependent pathogenicity of group B coxsackievirus in Swiss-webster mice: infectivity for myocardium and pancreas. J Infect Dis 1980; 141: 394–403

    Article  PubMed  CAS  Google Scholar 

  28. Walz-Cicconi MA, Weller TH. Dose related effects of acetylsalicylic acid on replication of zoster virus in vitro. Proc Natl Acad Sci U S A 1984; 81: 5223–6

    Article  PubMed  CAS  Google Scholar 

  29. Leclerc C, Morin A, Deriand E, et al. Inhibition of human IL2 production by MDP and derivates. J Immunol 1984; 133: 1996–2000

    PubMed  CAS  Google Scholar 

  30. Cockran FR, Baxter CS. Carrageenan-induced suppression of T-lymphocyte proliferation in the rat: abrogation of suppressor factor production by the prostaglandin synthesis inhibitors, indomethacin and ETYA. Immunobiology 1984; 166: 275–85

    Article  Google Scholar 

  31. Kato K, Askenase PW. Reconstitution of an inactive antigen-specific T cell suppressor factor by incubation of the factor with prostaglandins. J Immunol 1984; 133: 2025–31

    PubMed  CAS  Google Scholar 

  32. Factro SM, Minase T, Cho S, et al. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation 1982; 66: 342–54

    Article  Google Scholar 

  33. Sole MJ, Liu P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol 1993; 22Suppl. A: 99A–105A

    Article  PubMed  CAS  Google Scholar 

  34. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388–98

    Article  PubMed  CAS  Google Scholar 

  35. Grumbach IM, Heim A, Pring-Akerblom I, et al. Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy. Acta Cardiol 1999; 54: 83–8

    PubMed  CAS  Google Scholar 

  36. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure: relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984; 310: 347–52

    Article  PubMed  CAS  Google Scholar 

  37. Davie AP, Love MP, McMurray JJV. Even low-dose aspirin inhibits arachidonic acid-induced vasodilatation in heart failure. Clin Pharmacol Ther 2000; 67: 530–7

    Article  PubMed  CAS  Google Scholar 

  38. Spaulding C, Charbonnier B, Cohen-Solal A, et al. Acute haemodynamic interaction of aspirin and ticlopidine with enalapril. Circulation 1998; 98: 757–65

    Article  PubMed  CAS  Google Scholar 

  39. Mahe I, Meune C, Diemer M, et al. Interaction between aspirin and ACE inhibitors in patients with heart failure. Drugs Saf 2001; 24(3): 167–82

    Article  CAS  Google Scholar 

  40. Saxena A. Treatment of rheumatic carditis. Indian J Pediatr 2002; 69: 513–6

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr Bouvet for her help in reading the manuscript.

No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

  1. Cardiology Department and Department of Nuclear Medicine, Cochin Hospital, René Descartes University, 27 rue du Faubourg Saint-Jacques, Paris, 75014, France

    Christophe Meune & Christian Spaulding

  2. Internal Medicine, Lariboisière Hospital, Lariboisière-St Louis University, Paris, France

    Isabelle Mahé & Jean-François Bergmann

  3. Department of Virology, Cochin Hospital, René Descartes University, Paris, France

    Pierre Lebon

Authors
  1. Christophe Meune
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Spaulding
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isabelle Mahé
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pierre Lebon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jean-François Bergmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christophe Meune.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meune, C., Spaulding, C., Mahé, I. et al. Risks versus Benefits of NSAIDs Including Aspirin in Myocarditis. Drug-Safety 26, 975–981 (2003). https://doi.org/10.2165/00002018-200326130-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200326130-00005

Keywords

Search

Navigation